BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.88
Delayed Data
As of May 18
 -0.02 / -0.34%
Today’s Change
3.95
Today|||52-Week Range
7.39
+19.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues13.6M48.3M26.4M25.2M
 
 
 
 
 
Cost of Goods Sold33.5K1.7M2.2M998.0K
 
 
 
 
 
Depreciation And Amortization177.0K180.0K483.0K704.0K
 
 
 
 
 
 
Operating ExpensesGross Income13.4M46.4M23.7M23.5M
 
 
 
 
 
General Expenses59.2M85.8M72.3M80.9M
 
 
 
 
 
Research And Development51.8M72.8M61.0M67.0M
 
 
 
 
 
Total Operating Expenses59.4M87.7M75.0M82.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-45.8M-39.4M-48.6M-57.4M
 
 
 
 
 
Extraordinary Credit5.5M0.000.000.00
 
 
Extraordinary Charge0.00-564.0K-843.0K-821.0K
 
 
 
 
Interest Expense On Debt5.0M5.2M6.5M8.6M
 
 
 
 
 
Other Expenses0.001.7M11.0K1.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-45.2M-43.0M-55.1M-65.8M
 
 
 
 
 
Net Income-45.2M-43.0M-55.1M-65.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS66.8M72.9M73.7M84.5M
 
 
 
 
 
Shares To Calculate EPS Diluted66.8M72.9M73.7M84.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.68-$0.59-$0.75-$0.78
 
 
 
 
 
EPS Diluted-$0.68-$0.59-$0.75-$0.78